DCL
DCL (DCL) is a company in Vietnam's Health Care sector, listed on HOSE. The stock last traded at 44,000 VND, little changed on the session, giving a market capitalization of 2.8 trillion VND.
Return on equity of -0.4% points to weak profitability relative to the company's equity base, below the sector average of 11.3%. Trailing earnings per share stand at -92 VND.
Aveluro tracks 9 news items mentioning DCL, where recent coverage skews negative (44% of articles). The most recent catalyst was a sector sentiment event — "VN-Index Falls 0.94% as VIC, VHM, STB, HPG Drag; Mid-Caps Rally". Aveluro's composite model rates DCL 4.7/10 (Neutral), blending news sentiment, price momentum, and fundamentals.
Comparable names in the Health Care sector include AGP, AMP and AMV.
VN-Index Falls 0.94% as VIC, VHM, STB, HPG Drag; Mid-Caps Rally
Recent developments around DCL include 3 notable classified events. On Oct 19, 2026, a market event was reported: VIC slid 3.72% in a heavy afternoon sell-off, with VHM, STB and HPG also weighing on the VN-Index, which closed 0.94% lower at 1,689.84. On Sep 16, 2026, a leadership change was reported: Cuu Long Pharmaceutical (DCL) has removed Deputy General Director Nguyen Trong Duc, who oversaw production and supply chain, effective 16 September 2026 after he submitted his resignation. On Apr 29, 2026, an earnings beat was reported: VietinBank (CTG) reported Q1/2026 pre-tax profit of VND 11,139 billion, up 63% YoY, leading a mixed earnings season.
The overall tone of recent coverage is positive, with 1 of 3 events carrying bullish sentiment.
By Aveluro Research Team · Editorial policy · Caveat: Not investment advice. · How Aveluro computed this